Affiliation:
1. Federal State Budgetary Institution “Research Institute for Complex Problems of Cardiovascular Diseases”; Federal State Budget Educational Institution of Higher Professional Education “Kemerovo State Medical Academy”
2. Federal State Budgetary Institution “Research Institute for Complex Problems of Cardiovascular Diseases”
Abstract
Renal dysfunction (RD) in the acute phase of myocardial infarction (MI) is pivotal for the risk stratification of adverse long-term outcomes after myocardial infarction and, therefore, requires further study. Purpose. To determine the role of CKD and renal dysfunction (in the acute phase of MI) in the adverse long-term post-MI prognosis. Material and methods. 954 patients with ST-segment elevation myocardial infarction (STEMI) were enrolled in a registry study, performed in the period from 2008 to 2010 at the Kemerovo Cardiology Dispensary. All patients were assigned to two groups according to the presence of concomitant CKD. Serum creatinine levels were measured at the time of admission and on 10-12th days, with further calculation of glomerular filtration rate (GFR) using the CKD-EPI equation. Patients without CKD were assigned to Group I (n = 616 (64.5%), and STEMI patients with CKD to Group II (n=338 (35.4%). Observations during the three-year follow-up period were evaluated from the end-points. Results. The factors associated with mortality among patients with CKD were as follows: left ventricular ejection fraction (LVEF) < 40% at the time of admission (OR 2.1; 95% CI 1.0-4.4), signs of RD at the time of discharge (OR 2.5, 95% CI 1.0-5.9), non-performance of myocardial revascularization (OR 3.1, 95% CI 1.4-6.8). The long-term prognosis in the group of patients without CKD depended on the following factors: non-performance of PCI (OR 2.1, 95% CI 1.0-4.3), severe AHF (Killip class) (OR 3.5, 95% CI 1.9-6.7), LVEF < 40% (OR 2.0, 95% CI 1.0-3.8), and older age (OR 2.0, 95% CI 1.0-3.9). Conclusion. Renal dysfunction (regardless of the presence of CKD) diagnosed in the acute phase of MI as well as left ventricular dysfunction (EF < 40%) were found to affect long-term mortality risk in the post-MI period.
Publisher
Medical Informational Agency Publishers
Reference17 articles.
1. McCullough1 P.A., Haapio M., Mankad S., Zamperetti N., Massie B., Bellomo R., et al. Prevention of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference. Nephrol. Dial. Transplant. 2010; 25(6): 1777—84. Doi: 10.1093/ndt/gfq180
2. Korzh A.N. Cardiorenal syndrome in CAD patients with chronic kidney disease. Pochki. 2015; 1(11): 45—51. (in Russian)
3. Smirnov A.V., Shilov E.M., Dobronravova V.A., Kayukov I.G., Bobkova I.N., Tsygin A.N. et al. National Guidelines. Chronic Kidney Disease: Basic Principles of Screening, Diagnosis, Prevention and Treatment Approaches. St. Peitersburg: Levsha; 2013. (in Russian)
4. Bagshaw S.M., Cruz D.N., Aspromonte N., Daliento L., Ronco F., Sheinfeld G. et al. Epidemiology of cardio-renal renal syndromes: workgroup statements from the 7th ADQI Consensus Conference. Nephrol. Dial. Transplant. 2010; 25: 1406—16. Doi: 10.1093/ndt/gfq066
5. Selby N.M., McIntyre C.W. The acute cardiac affects of dialysis. Semin. Dialis. 2007; 20: 220—8. DOI: 10.1111/j.1525139X.2007.00281.x
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献